(0.05%) 5 472.13 points
(0.10%) 39 149 points
(0.36%) 17 782 points
(0.02%) $80.85
(-3.66%) $2.66
(-0.80%) $2 312.20
(0.16%) $28.92
(3.51%) $1 021.00
(0.27%) $0.936
(0.70%) $10.68
(0.44%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network...
Stats | |
---|---|
今日成交量 | 32 203 |
平均成交量 | 206 070 |
市值 | 27.67M |
EPS | $-0.290 ( Q1 | 2024-05-20 ) |
下一个收益日期 | ( $0 ) 2024-08-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.440 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00600 (1.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Miller Victor | Sell | 25 000 | Stock Option (Right to Buy) |
2024-04-01 | Miller Victor | Buy | 25 000 | Common Stock |
2024-02-01 | Safier Jacob | Buy | 10 100 | Common Stock (par value $0.01) |
2024-01-31 | Safier Jacob | Buy | 5 000 | Common Stock (par value $0.01) |
2024-01-30 | Safier Jacob | Buy | 25 000 | Common Stock (par value $0.01) |
INSIDER POWER |
---|
93.39 |
Last 93 transactions |
Buy: 2 511 105 | Sell: 463 608 |
音量 相关性
Orgenesis Inc 相关性 - 货币/商品
Orgenesis Inc 财务报表
Annual | 2023 |
营收: | $530 000 |
毛利润: | $-5.73M (-1 080.19 %) |
EPS: | $-1.910 |
FY | 2023 |
营收: | $530 000 |
毛利润: | $-5.73M (-1 080.19 %) |
EPS: | $-1.910 |
FY | 2022 |
营收: | $36.03M |
毛利润: | $15.59M (43.26 %) |
EPS: | $-0.480 |
FY | 2021 |
营收: | $35.50M |
毛利润: | $-1.14M (-3.22 %) |
EPS: | $0.744 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Orgenesis Inc
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。